Literature DB >> 7108271

Incidence of hepatitis B virus infections in preschool children in Taiwan.

R P Beasley, L Y Hwang, C C Lin, M L Leu, C E Stevens, W Szmuness, K P Chen.   

Abstract

To determine the incidence of infections with hepatitis B virus (HBV) among Chinese preschool children, 1,510 children (mean age, 29 months) were tested for HBV markers; 15.9% were infected with HBV (7.8% positive for hepatitis B surface antigen [HBsAg] and 8.1% positive for antibody to HBsAg) and 84.1% were susceptible when the children were enrolled in the study. The average length of follow-up was 2.1 years among 1,110 children. Among the 924 susceptible children who were followed up, 10.6% had seroconversions for HBV markers, none of which was associated with clinical illness; the annual incidence of HBV infections was 5.0%. Among the 98 children who experienced HBV infections during the study, 23% became HBsAg carriers, and HBsAg persistence was age-related, with most carriers being among the youngest children infected. In contrast, among the children with HBV markers at the time of enrollment, 118 (49.2%) were HBsAg-positive and 86% were still positive on follow-up. The incidence of HBV infections was significantly associated with the frequency of previous injections.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7108271     DOI: 10.1093/infdis/146.2.198

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  59 in total

1.  Interferon-alpha for reinfection with hepatitis C virus in two patients with chronic hepatitis C who had responded to previous therapies.

Authors:  Norio Akuta; Fumitaka Suzuki; Akihito Tsubota; Yoshiyuki Suzuki; Takashi Someya; Masahiro Kobayashi; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Yuzo Miyakawa; Hiromitsu Kumada
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

2.  Hepatitis B prevention and control: Lessons from the East and the West.

Authors:  Monica C Robotin
Journal:  World J Hepatol       Date:  2011-02-27

Review 3.  Hepatitis B immunization strategies: timing is everything.

Authors:  Christopher O Mackie; Jane A Buxton; Sayali Tadwalkar; David M Patrick
Journal:  CMAJ       Date:  2009-01-20       Impact factor: 8.262

4.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors:  Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal:  Hepatology       Date:  2018-04       Impact factor: 17.425

Review 5.  Chronic viral hepatitis.

Authors:  M H Chang
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

6.  Screening of pregnant women for hepatitis B markers in a French Provincial University Hospital (Limoges) during 15 years.

Authors:  François Denis; Sylvie Ranger-Rogez; Sophie Alain; Marcelle Mounier; Caroline Debrock; Anne Wagner; Christian Delpeyroux; Jean Louis Tabaste; Yves Aubard; Pierre-Marie Preux
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

7.  How often does chronic liver disease follow acute hepatitis B in adults?

Authors:  A Roumeliotou-Karayannis; N Tassopoulos; S C Richardson; P Kalafatas; G Papaevangelou
Journal:  Infection       Date:  1985 Jul-Aug       Impact factor: 3.553

8.  Transmural suture technique for trocar-site bleeding following laparoscopic cholecystectomy.

Authors:  S H Chao; P H Lee
Journal:  Surg Endosc       Date:  1994-10       Impact factor: 4.584

9.  Hepatitis B virus among Saudi children in Gizan, Saudi Arabia.

Authors:  C M Parande; S C Arya; S J Ashraf
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

10.  Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study.

Authors:  Meng-Shen Dai; Pei-Fen Wu; Jang-Jih Lu; Rong-Yaun Shyu; Tsu-Yi Chao
Journal:  Support Care Cancer       Date:  2004-03       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.